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Ear infection is one of the common diseases occurring throughout the world. Different etiological 
agents are responsible for ear infections.
Aim: To assess the antimicrobial potential of Terminalia arjuna leaves and bark extracts against 
Staphylococcus aureus, Acinetobacter sp., Proteus mirabilis, Escherchia coli, Pseudomonas aerugi-
nosa and Candida albicans, pathogens causing ear infections and their comparison with locally 
available ear drops.
Materials and Methods: Methanol, ethanol, acetone, aqueous (hot and cold) extracts from the 
leaves and bark of T. arjuna were tested for their antimicrobial activity.
Results: Of the three organic solvents evaluated, acetonic leaf extract was found to be best against 
S. aureus. Organic bark extract showed almost equal inhibition of all tested Gram negative bacteria 
except P. aeruginosa. However, aqueous extract of T. arjuna bark exhibited good activity against 
S. aureus. All the extracts were unable to exhibit any antifungal activ¬ity.
Conclusion: Organic extract obtained from the T. arjuna bark and leaves may be used to treat 
the bacterial ear pathogens especially S. aureus, which has shown greater inhibition zones than the 
herbal drops, however, we still need more detailed studies as in vivo testing and pharmacokinetics 
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INTRODUCTION
Ear infection is more common in children than 
adults, approximately 75% of children experience at 
least three or more ear infections during the first three 
years of life1. Ear infection is mainly caused by bacterial 
(Pseudomonas aeruginosa, Staphylococcus aureus, S. 
epidermidis, Streptococcus pneumoniae, Escherichia coli, 
Proteus mirabilis) and fungal pathogens (Aspergillus niger, 
A. fumigatus, A. flavus, Candida albicans)2-5.
The clinical efficacy of many existing chemothe-
rapeutic agents is being threatened by the emergence of 
multidrug-resistant pathogens. Bacteria naturally develop 
resistance to antimicrobial drugs. In recent years, however, 
the overuse and misuse of antibiotics has caused a growing 
number of staphylococcus bacteria to evolve into disease 
causing “superbugs” resistant to drugs like methicillin, 
vancomycin6-8. The increasing failure of chemotherapeutics 
and antibiotic resistance exhibited by pathogenic microbial 
infectious agents has led to the screening of several plants 
for their potential antimicrobial activity and development 
of new antimicrobials by drug companies7,9. Herbs are sta-
ging a comeback and herbal ’renaissance’ is happening all 
over the globe and according to WHO, 80% of the world’s 
population relies on plant-based traditional medicines for 
their primary healthcare needs10-12. 
Nature has bestowed India with rich flora that is 
widely distributed. Herbal medicines have been used for 
the treatment and cure of various diseases in the Indian 
traditional practiced methods such as Ayurveda, Unani and 
Siddha13,14. Terminalia arjuna Wight & Arn., commonly 
called arjuna (family Combretaceae), is a deciduous and 
evergreen tree distributed throughout India and also found 
in Burma, Srilanka and Mauritius, growing up to a height of 
60 to 90 feet. Leaves of arjuna are simple, oblong or elliptic 
with pale and dark green upper surface and pale brown 
lower surface. Flowers are bisexual, sessile and white 
arranged in short axillary spikes or in terminal pannicule. 
The bark is smooth, pinkish-grey from outside and flakes 
off in large, curved and rather flat pieces15,16. The bark and 
leaves of this plant have been used in indigenous system 
of medicine for curing different diseases, the bark in the 
treatment for angina (hritshool),expectorant, antidysentric, 
purgative, laxative, leucoderma, anaemia, hyperhidrosis, 
asthama, tumors and other cardiovascular disorders16,17 
and leaves as a remedy for the treatment of ear ache18. 
The bark also possesses good anticancer, antiviral and 
antimicrobial activities19,20.
Plants have limitless ability to synthesize secondary 
metabolites such as tannins, terpenoids, alkaloids, flavo-
noids, glycosides and phenols which have been found to 
have antimicrobial properties11,21,22. The leaves and bark 
of T. arjuna contain glycosides having cardio protective 
effect, flavanoids having antioxidant, anti-inflamatory, 
antimicrobial (luteolin), anti cancerous and lipid lowering 
effects, tannins responsible for astringent, wound healing, 
antioxidant, anti cancer, anti viral and antimicrobial activity. 
In addition to these phytocompounds bark also contains 
triterpenoids responsible mainly for cardio protective 
and antibacterial (arjunic acid, arjungenin and, arjunetin) 
effect15,16,23.
A wide variety of medicinal plants used traditionally 
have not yet been systematically investigated against va-
rious microbial pathogens24. Literature search reveals the 
conducting of a few studies on antibacterial and antifungal 
activity of various parts of this plant, such as bark23.25,26, 
leaves, root and fruit15,27,28. However, antimicrobial studies 
against pathogens causing ear infection are lacking. The 
present study was carried out to validate the antimicrobial 
potential of T. arjuna leaves and bark against the bacterial 
and fungal ear pathogens isolated from the local patients 
of Kurukshetra and their comparison with locally available 
ear drops with a view of searching a novel extract as a 
remedy for treating ear infections.
MATERIAL AND METHODS
Plant collection
The bark and leaves of Terminalia arjuna were 
collected from the trees alongside the roads of University 
of Kurukshetra, Haryana. The taxonomic identity of this 
plant was confirmed by Dr. B.D. Vashishta of Botany De-
partment, Kurukshetra University, Kurukshetra.
Extraction of plant material
The samples were carefully washed under running 
tap water followed by sterile distilled water and air dried 
at room temperature (40°C) for 4-5 days and then homo-
genized to a fine powder using a sterilized mixer grinder 
and stored in air tight bottles. Four different solvents 
namely ethanol, methanol, acetone and aqueous (hot 
and cold) were used for extraction. A 10 g amount of 
homogenized bark and leaves were separately soaked in 
conical flasks each containing100 ml of acetone, ethanol, 
methanol (95%) and sterile distilled water. Also the same 
amount (i.e. 10 g) of homogenized bark and leaves were 
immersed separately in 100 ml of hot sterile distilled wa-
ter in conical flasks and allowed to stand for 30 min on a 
waterbath with occasional shaking followed by keeping 
all the flasks on rotary shaker at 200 rpm for 24 h29-31. Each 
preparation was filtered through a sterilized Whatman No. 
1 filter paper and finally concentrated to dryness under 
vacuum at 40°C using rotaevaporator. The dried extract 
thus obtained was sterilized by overnight UV-irradiation 
and checked for sterility on nutrient agar plates and stored 
at 4°C in labeled sterile bottles until further use14,32.
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Test microorganisms
Five bacteria namely Staphylococcus aureus 
(HM626197)* (Gram-positive), Acinetobacter sp. 
(HM626198), Proteus mirabilis (HM626199), Escherchia 
coli (HM626200), Pseudomonas aeruginosa (HM626201) 
(Gram-negative) and one yeast, Candida albicans used in 
this study, were isolated from the patients having ear in-
fection from the local ENT clinics of Kurukshetra. Bacterial 
strains were identified on the basis of staining, biochemical 
and molecular characteristics (16S rRNA sequencing)33 and 
yeast on the basis of staining, morphological and cultural 
characteristics5,34,35. The bacterial isolates were subcultured 
on Nutrient agar and yeast on Malt yeast agar and incu-
bated aerobically at 37oC.The media were procured from 
Hi Media Laboratory Pvt. Ltd., Bombay, India.
Ear drops
Three commonly prescribed ear drops by otolaryn-
gologist, two allopathic Ciplox (antibacterial), Candid (an-
tifungal), and a herbal ear drop Bilwa Tel (antimicrobial), 
used in this study, were procured from the local market 
of Kurukshetra.
Screening for antimicrobial activity
The acetone, methanol, ethanol, hot and cold 
aqueous T. arjuna leaves and bark extracts were used for 
evaluation of the antimicrobial activity by the agar well 
diffusion method36,37. In this method, pure isolate of each 
microbe was subcultured on the agar media plates at 370C 
for 24 h. One plate of each microorganism was taken and 
a minimum of four colonies were touched with a sterile 
loop and transferred into normal saline (0.85%) under 
aseptic conditions. Density of each microbial suspension 
was adjusted equal to that of 106 cfu/ml (standardized 
by 0.5McFarland standard) and used as the inoculum 
for performing agar well diffusion assay. One hundred 
microlitre (100μl) of inoculum of each test organism was 
spread onto the agar plates so as to achieve a confluent 
growth. The agar plates were allowed to dry and wells of 
8mm were made with a sterile borer in the inoculated agar 
plates and the lower portion of each well was sealed with 
a little specific molten agar medium. The dried extracts 
were reconstituted in 20% dimethylsulphoxide (DMSO) 
for the bioassay analysis38. A 100μl volume of each extract 
was propelled directly into the wells (in triplicates) of the 
inoculated agar plates for each test organism. The plates 
were allowed to stand for 1hr for diffusion of the extract 
into the agar and incubated at 37OC for 24h.32,39. Sterile 
DMSO (20%) served as the negative control and ciplox (for 
bacteria), candid (for fungi) and Bilwa tel (antimicrobial) 
ear drop served as the positive control. The antimicrobial 
activity, indicated by an inhibition zone surrounding the 
well containing the extract, was recorded if the zone of 
inhibition was greater than 8mm40. The experiments were 
performed in triplicates and the mean values of the dia-
meter of inhibition zones with ± standard deviation were 
calculated.
Determination of minimum inhibitory concentration 
(MIC)
MIC for each test organism was determined by 
following the modified agar well diffusion method. A 
twofold serial dilution of each extract was prepared by 
first reconstituting the dried extract (100 mg/ml) in 20% 
DMSO followed by dilution in sterile distilled water (1:1) 
to achieve a decreasing concentration range of 50mg/ml 
to 0.39mg/ml. A 100 μl volume of each dilution was intro-
duced into wells (in triplicate) in the agar plates already 
seeded with 100μl of standardized inoculum (106 cfu/ml) 
of the test microbial strain. All test plates were incubated 
aerobically at 37oC for 24 hrs and observed for the inhibi-
tion zones. MIC, taken as the lowest concentration of the 
test extract that completely inhibited the growth of the 
microbe, showed by a clear zone of inhibition (>8mm), 
was recorded for each test organism32, 37,41, 42.
Statistical analysis
All data were presented as mean ± SD (Standard de-
viation). Results were statistically evaluated using Dennett’s 
T-test. P value less than 0.01 were considered significant.
RESULTS
The antibacterial activity of T. arjuna bark and lea-
ves extracts on the agar plates varied in different solvents. 
Of the ten extracts screened for antifungal activity, none 
of the extract showed the production of inhibition zone 
against Candida albicans thus lacking antifungal activity. 
Positive controls produced significantly sized inhibition 
zones against the tested bacteria and yeast, however, 
negative control produced no observable inhibitory effect 
against any of the test organism (Table 1). 
A perusal of the data in Table 1 reveals that all the 
six organic solvent extracts of both leaves and bark pos-
sessed antibacterial activity against the four bacterial patho-
gens, of the five tested pathogens. The acetonic leaf extract 
was found to be most effective against Staphylococcus 
aureus (28mm) (Figure 1) followed by Proteus mirabilis 
(27.6mm), Acinetobacter sp (16.6mm) and Pseudomonas 
aeruginosa (16mm). The inhibiton zones produced by 
the methanolic and ethanolic extracts against S. aureus 
and P.mirabilis ranged between 24.6mm and 26.3 mm. S. 
aureus and P.mirabilis were found to be most sensitive 
pathogens which survived upto 1.56 mg/ml and 3.12 mg/
ml (Table 2), thus having an MIC of 3.12 mg/ml and 6.25 
mg/ml, respectively. The inhibition zone produced by the 
organic leaf extracts against P. aeruginosa and Acitenobac-
* Nucleotide sequence of all the five bacteria have been submitted to GenBank database, which 
have provided GenBank accession number, HM626197-HM626201.
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ter sp. ranged between 15mm and 16.6mm. P. aeruginosa 
and Acitenobacter sp. were found to be comparatively less 
sensitive as they survived up to 25mg/ml (methanolic and 
ethanolic extracts) and 12.5mg/ml (acetonic extract) thus 
having an MIC of 50 mg/ml and 25 mg/ml, respectively. 
No antibacterial activity was observed in aqueous and 
organic leaf extracts against E. coli.
Among the tested bark extracts, all the five solvent 
extracts (organic and aqueous) showed antibacterial ac-
tivity against S. aureus with highest zone of inhibition in 
hot aqueous extract (27.6mm) followed by cold aqueous 
extract (26.3mm) (Figure 2), ethanol extract (26mm), me-
thanol and acetone extracts (23mm). S. aureus was again 
found to be the most sensitive pathogen which survived 
upto lowest concentration i.e.0.78 mg/ml in hot water, cold 
water and ethanol extracts (Table 2), thus having an MIC 
of 1.56 mg/ml followed by the methanolic and acetonic 
extracts 3mg/ml. The inhibition zones produced by the 
three organic solvents against Acitenobacter sp. ranged 
between 16.3mm and 17mm. Acitenobacter sp. was com-
paratively less sensitive as it survived upto 12.5 mg/ml, 
thus having an MIC of 25mg/ml. The zone of inhibition 
produced by the organic solvent bark extracts against P. 
mirabilis and Escherchia coli was almost equal and ran-
ged between 14.6mm and 16.3mm. P. mirabilis survived 
up to 12.5mg/ml (acetone) and 25mg/ml (methanol and 
ethanol), thus having an MIC of 25mg/ml and 50 mg/ml 
respectively while E. coli survived upto 25mg/ml (ethanol 
and acetone) and 12.5mg/ml (methanol) thus having an 
MIC of 50 mg/ml and 25 mg/ml, respectively. Bark extracts, 
both organic and aqueous, however, lacked antibacterial 
activity against P.aeruginosa. All the obtained results are 
statistically significant as they showed (p < 0.001) as com-
pared with control.
Table 1. Antimicrobial activity of Terminalia arjuna leaves and bark extract on ear pathogens determined by agar well diffusion 
method.
Arjuna plant





Proteus mirabilis Escherchia coli Acitenobacter Sp. Candida albicans
Leaves extracts (mg/ml)
Methanol 25.6*a ±0.57b 16.3±0.57 24.6±0.57 - 15±0 -
Ethanol 26.3±0.57 15.6±0.57 26±0 - 15.3±0.57 -
Acetone 28±0 16±0 27.6±0.57 - 16.6±0.57 -
Hot aqueous - - - - - -
Cold aqueous - - - - - -
Bark extracts (mg/ml)
Methanol 23.6±0.57 - 15±0 15.6±0.57 17±0 -
Ethanol 26±0 - 14.6±0.57 15±0 16.3±0.57 -
Acetone 23.3±0.57 - 16.3±0.57 15.6±0.57 17.6±0.57 -
Hot aqueous 27.6±0 .57 - - - - -
Cold aqueous 26.3±0.57 - - - - -
DMSO 0 0 0 0 0 0
Ciplox ear drop 56.3±0.57 34±0 46.3±0.57 36±0 32.6±0.57 nt
Bilva tel ear drop 13.6±0.57 - 11.6±0.57 - - -
Candid ear drop nt nt nt nt nt 21.3±0.57
- No activity, nt = not tested.
a Values, including diameter of the well (8mm), are means of three replicates b ± Standard deviation. The data were analyzed by one way ANOVA 
followed by Dunnett’s t test. *p<0.01 compared to positive control.
Figure 1. Zone of antibacterial inhibition of T. arjuna leaves organic 
extracts against S. aureus by acetonic (A), methanolic (B), ethanolic 
extract (C), and negative control DMSO (D).
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DISCUSSION
The organic extracts of T. arjuna leaves possessed 
good activity against the four bacterial ear pathogens na-
mely Staphylococcus aureus, Pseudomonas aeruginosa, 
Proteus mirabilis, Acitenobacter sp. and did not exhibit 
any activity against E. coli. Interestingly, the bark extract 
also showed good bioactivity against the four bacterial ear 
pathogens, however, P. aeruginosa was not found sensitive 
to the bark extracts. The antifungal activity against C. albi-
cans was totally absent in the both organic and aqueous 
T. arjuna leaf and bark extracts. In earlier study, the root 
extracts of this plant had been shown to possess activity 
against Aspergillus niger and Candida albican27.
The aqueous leaves and bark extracts of T. arjuna 
lacked antifungal activity against C. albicans and antibac-
terial activity against the tested bacteria except a Gram 
positive bacterium, S. aureus that was found sensitive both 
to the hot and cold aqueous bark extracts. The limited 
spectrum of antimicrobial activity in the aqueous extracts 
may be due to three reasons: firstly the polarity of antibac-
terial compounds make them more readily extracted by 
organic solvents as compared to aqueous extract; secondly 
active compound may be present in insufficient amount 
in the crude extract to show activity with the dose level 
employed; and thirdly if the active principle is  present in 
high quantities, there could be other constituents present 
in the extract exerting antagonistic effects of the bioactive 
compounds43.
Of the three organic extracts of leaves screened, 
the acetonic extract has been found to have a better an-
tibacterial activity than the corresponding ethanolic and 
methanolic extracts (Table 1) thus substituting the findings 
of earlier workers11,37,44,45 who rated acetone as the best 
solvent. The antibacterial activity exhibited by T. arjuna 
leaves and bark extracts against the bacterial ear pathogens 
might be due to the presence of secondary metabolites 
such as arjunic acid, arjungenin , arjunetin and luteolin whi-
ch have been reported to be antimicrobial in nature15,16,23.
This study reveals that both the leaves and bark 
organic extracts of T. arjuna have broad spectrum anti-
bacterial activity against the ear pathogens as visualized 
by the formation of inhibition zones of both Gram positive 
and Gram negative bacteria. Interestingly, all the organic 
extracts of this plant showed much more potent activity 
against the tested ear bacteria than that of standard herbal 
ear drop (Bilwa tel) thus having a great potential to be 
developed as a herbal ear drop to control the bacterial 
ear infections. 
CONCLUSIONS
Our results allow us to conclude that, all the tested 
T.arjuna extracts (in any of the tested preparation-acetone, 
Arjuna MIC (mg/ml)
plant Staphylococcus aureus Pseudomonas aeruginosa Proteus mirabilis Escherchia coli Acitenobacter Sp.
Leaves extracts
Methanol 6.25 50 6.25 nt 50
Ethanol 6.25 50 6.25 nt 50
Acetone 3.12 25 3.12 nt 25
Bark extracts
Methanol 3.12 nt 50 25 25
Ethanol 1.56 nt 50 50 25
Acetone 3.12 nt 25 50 25
Hot aqueous 1.56 nt nt nt nt
Cold aqueous 1.56 nt nt nt nt
Table 2. MIC of Terminalia arjuna leaves and bark extract on ear pathogens determined by modified agar well diffusion method.
nt = not tested
Figure 2. Zone of antibacterial inhibition of T. arjuna bark aqueous 
extracts against S. aureus by hot aqueous (A), cold aqueous extract 
(B), and negative control DMSO (C).
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ethanol or methanol) have shown good activity against 
both the Gram positive and Gram negative ear pathogens, 
the inhibition being higher in Gram positive bacteria than 
the Gram negative bacteria.This probably explains the use 
of this plant by the indigenous people against a number 
of infections since generations. As of now, little work has 
been done on the antimicrobial activity and plausible 
medicinal applications of the phytochemical compounds 
and hence extensive investigations are needed such as in 
vivo studies on this plant necessary to determine toxicity of 
the active constituents, their side effects, pharmacokinetics 
properties to exploit the bioactive principles, for therapeu-
tic utility in treating the ear infections. The antibacterial 
activities can be enhanced if the active components are 
purified and adequate dosage determined for proper ad-
ministration. At last, the need of the hour is the develop-
ment of an effective phytocompound into an exploitable 
herbal product, which is devoid of side effects and drug 
resistance problem.
REFERENCES
 1. Gates GA. Consideration of Otitis Media treatment. Otolaryngol Head 
Neck Surg. 1996;114(4):525-30.
 2. Roland PS, Stroman DW. Microbiology of acute otitis externa. La-
rygoscope. 2002;112(7 Pt 1):166-77.
 3. Rosenfeld RM, Brown L, Cannon RC, Dolor JR, Ganiats GT, Hannley 
M, et al. Clinical practice guideline: Acute otitis externa. American 
Acad Otolaryngology-Head and Neck Surgery Foundation. 2006;134(4 
Suppl):s4-s23.
 4. Dhingra PL. Diseases of Ear, Nose and Throat. 4th ed. New Delhi: 
Reed Elsevier India. Private Limited; 2007.
 5. Aneja KR, Sharma C, Joshi R. Fungal infection of the ear: A common 
problem in the north eastern part of Haryana. Int J Ped Otorhinola-
ryngol. 2010;74(6):604-7.
 6. Bandow JE, Brotz H, Leichert LIO, Labischinski H, Hecker M. Prote-
omic approach to understanding antibiotic action. Antimicrob Agents 
Chemother. 2003;47(3):948-55.
 7. Anonymous. Fighting superbugs. CQ Researcher. 2007;17(29):673-96.
 8. Aneja KR, Sharma C, Joshi R. Antimicrobial susceptibility pattern of 
common human pathogenic bacteria and yeasts against commercially 
available drugs. In: R Lawrence, AK Gulati, G Abraham. Antimicrobial 
Resistance: From Emerging Threat to Reality; 2009, New Delhi: Narosa 
Publishing House. p. 84-90.
 9. Scazzocchio F, Cometa MF, Tomassini L, Palmery M. Antibacterial 
activity of Hydratis canadensis extract and its major isolated alkaloids. 
Planta Med. 2001;67(6):561-4.
10. Clark AM. Natural products as a resource for new drugs. Pharmacy 
Research. 1996;13(8):1133-44. 
11. Cowan, MM. Plant products as antimicrobial agents. Clin Microbiol 
Rev. 1999;12(4):564-82.
12. WHO. Traditional Medicine: Growing needs and potential. WHO 
Policy Perspectives on Medicine. World Health Organization: Geneva; 
2002. p. 1-6.
13. Dahanukar SA, Kulkarni RA, Rege NN. Pharmacology of medicinal 
plants and natural products. Indian J Pharmacol. 2000;32(4):S81-S118.
14. Kumar VP, Chauhan NS, Padh H, Rajani M. Search for antibacterial 
and antifungal agents from selected Indian medicinal plants. J Eth-
nopharmacol. 2006;107(2):182-8.
15. Dwivedi S. Terminalia arjuna Wight & Arn.-A useful drug for car-
diovascular disorders. J Ethnopharmacol. 2007;114(2):114-29.
16. Jain S, Yadav PP, Gill V, Vasudeva N, Singla N. Terminalia arjuna a 
sacred medicinal plant; phytochemical and pharmacological profile. 
Phytochem Rev. 2009;8(2):491-502.
17. Udupa KN. Scope of use of Terminalia arjuna in ischaemic heart 
disease. Ann Natl Acad Indian Med. 1986;1:54.
18. Khory RN. The Bombay material medica and their therapeutics. 
Renina’s Union Press; 1867.
19. Tripathi VK, Singh B. Terminalia arjuna- its present status (a review). 
Orient J Chem. 1996;12(1):1-16.
20. Cooper EL. CAM, eCAM, Bioprospecting: the 21st century pyramid. 
Evid Based Compliment Alternat Med. 2005;2(2):125-7.
21. Sher A. Antimicrobial activity of natural products from medicinal 
plants. Gomal J Med Sci. 2009;7(1):72-8.
22. Das K, Tiwari RKS, Shrivastava DK. Techniques for evaluation of 
medicinal plant products as antimicrobial agent: Current methods 
and future trends. J Med Plants Res. 2010;4(2):104-11.
23. Singh DV, Gupta MM, Kumar TRS, Saikia D, Khanuja SPS. Anti-
bacterial principles from the bark of Terminalia arjuna. Curr Sci. 
2008;94(1):27-9.
24. Farrukh A, Iqbal A. Broad spectrum antibacterial and antifungal 
properties of certain traditionally used Indian medicinal plants. World 
J Microbiol Biotechnol. 2003;19(6):653-7.
25. Aggarwal RR, Dutt S. Chemistry, pharmacology and therapeutic ac-
tions of Terminalia arjuna. Proc Nat Acad Sci. 1936;6:305.
26. Perumalsamy R, Ignacimuthu S, Sen A. Screening of 34 Indian 
Medicinal plants for antibacterial properties. J Ethnopharmacol 
1998;62(2):173-82.
27. Chouksey BK, Srivastava SK. Antifungal agent from Terminalia 
arjuna. Indian J Chem. 2001;40B:354-6.
28. Ramya S, Kalaivani T, Rajasekaran C, Jepachanderamohan P, Alaguc-
hamy N, Kalayasundaram M, et al. Antimicrobial activity of aqueous 
extracts of bark, root, leaves and fruits of Terminalia arjuna Wright 
& Arn. Ethanobotanical leaflets. 2008;12:1192-7.
29. Akueshi CO, Kadiri CO, Akueshi EU, Agina SE, Ngurukwem B. An-
timicrobial potential of Hyptis sauvedena Poit (Lamisceae). Nigeria J 
Bot. 2002;15(1):37-41.
30. Ogundiya MO, Okunade MB, Kolapo AL. Antimicrobial ac-
tivities of some Nigerian Chewing Sticks. Ethnobotanical leaflets. 
2006;10:265-71.
31. Preethi R, Devanathan VV, Loganathan M. Antimicrobial and antioxi-
dant efficacy of some medicinal plants against food borne pathogens. 
Advances Biol Res. 2010;4(2):122-5.
32. Okeke MI, Iroegbu CU, Eze EN, Okoli AS, Esimone, CO. Evaluation 
of extracts of the roots of Landolphia owerrience for antibacterial 
activity. J Ethnopharmacol. 2001;78(2-3):119-27.
33. Lawongsa P, Boonkerd N, Wongkaew S, O Gara F, Teaumroong N. 
Molecular and phenotypic characterization of potential plant growth- 
promoting Pseudomonas from rice and maize rhizospheres. World 
J Microbiol Biotechnol 2008; DOI 10.1007/s11274-008-9685-7.
34. Aneja KR. Experiments in Microbiology, Plant Pathology and Biotech-
nology. 4th ed. New Delhi: New Age International Publishers; 2003.
35. Cappuccino JG, Sherman N. Microbiology Lab Manual. 7th ed. USA: 
Benjamin Cummings Publishing Company; 2008.
36. Ahmad I, Beg AZ. Antimicrobial and phytochemical studies on 45 
Indian medicinal plants against multi-drug resistant human pathogens. 
J Ethnopharmacol. 2001;74(2):113-23.
37. Aneja KR, Joshi R, Sharma C. Antimicrobial activity of Dalchini 
(Cinnamomum zeylanicum bark) extracts on some dental caries 
pathogens. J Phar Res. 2009;2(9):1370-2.
38. Rajasekaran C, Meignanam E, Vijayakumar V, Kalaivani T, Ramya 
S, Premkumar N, et al. Investigation on antibacterial activities of 
leaf extracts of Azadirachta indica A. Juss (Meliaceae) a traditional 
medicinal plant of India. Ethnabotanical Leaflets. 2008;12:1213-7.
39. Rios JL, Recio MC, Villar A. Screening methods for natural products 
with antibacterial activity: a review of the literature. J Ethnopharmacol. 
1980;23(2-3):127-49.
78(1)-ing.indb   73 03/02/2012   16:39:29
74
Brazilian Journal of otorhinolaryngology 78 (1) January/feBruary 2012
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
40. Hammer KA, Carson CF, Riley TV. Antimicrobial activity of essential 
oils and other plant extracts. J App Microbiol. 1999;86(6):985-90.
41. Thongson C, Davidson PM, Mahakarnchanakul W, Weiss J. Antimi-
crobial activity of ultra sound- assisted solvent - extracted spices. Lett 
Appl Microbiol. 2004;39(5):401-6.
42. Nkere CK, Iroegbu CU. Antibacterial screening of the root, seeds 
and stem bark extracts of Picralima nitida. Afr J Biotechnol. 
2005;4(6):522-6
43. Sangetha SN, Zuraini Z, Sasidharan S, Suryani S. Antimicrobial ac-
tivities of Cassia surattensis and Cassia fistula. J Mol Bio Biotech. 
2008;1(1):1-4.
44. Eloff JN. Which extractant should be used for the screening and iso-
lation of antimicrobial components from plants? J Ethnopharmacol. 
1998;60(1):1-8.
45. Nair R, Kalariya T, Sumitra C. Antibacterial activity of some selected 
Indian medicinal plants. Turk J Biol. 2005; 29(1):41-7.
78(1)-ing.indb   74 03/02/2012   16:39:29
